AVTR
Avantor, Inc.
$10.51
+0.75 (+7.68%)
At close · Jul 9
Market Cap
$7.13B
Shares
682,755,402
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$6.55B
-3.4%
FY2025
Net Income
-$530.2M
-174.5%
FY2025
Gross Margin
32.65%
-1pp
FY2025
Operating Margin
-3.76%
-19.8pp
FY2025
Diluted EPS
-$0.78
-175%
FY2025
Operating Cash Flow
$623.8M
-25.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $6.55B | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.04B | |
| $4.45B | $4.41B | $4.5B | $4.6B | $4.91B | $4.88B | $4.12B | |
| $2.11B | $2.14B | $2.28B | $2.36B | $2.6B | $2.5B | $1.92B | |
| — | 32.65% | 33.6% | 33.93% | 34.65% | 33.88% | 31.8% | |
| $1.61B | $1.6B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | |
| — | $301.1M | $299.8M | $307.7M | $318.3M | $290.8M | $312.3M | |
| $415.5M | $410.2M | $405.5M | $402.3M | $405.5M | $379.2M | $398.9M | |
| — | $29.8M | $82.8M | $26.5M | $3.5M | $5.3M | $24.3M | |
| -$294.1M | -$246.2M | $1.08B | $696.4M | $1.13B | $972.2M | $551.8M | |
| — | -3.76% | 15.99% | 10% | 15.04% | 13.16% | 9.14% | |
| $121.4M | $164M | $1.49B | $1.1B | $1.54B | $1.35B | $950.7M | |
| $170.5M | $169.8M | $218.8M | $284.8M | $265.8M | $217.4M | $440M | |
| -$1.7M | -$20.7M | -$1.2M | $5.8M | -$800K | $10.6M | $2.5M | |
| -$471.5M | -$441.3M | $853.9M | $410.5M | $851.1M | $753M | $40.6M | |
| $79.9M | $88.9M | $142.4M | $89.4M | $164.6M | $180.4M | $2.8M | |
| -$551.4M | -$530.2M | $711.5M | $321.1M | $686.5M | $572.6M | $37.8M | |
| — | -8.09% | 10.49% | 4.61% | 9.14% | 7.75% | 0.63% | |
| — | — | — | — | — | — | $0 | |
| -$551.4M | -$530.2M | $711.5M | $321.1M | $662.3M | $508M | -$335.1M | |
| -$477.4M | -$363.1M | $596.5M | $352.4M | $629.4M | $507.7M | $18.4M | |
| USD/shares | — | -$0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.10 |
| USD/shares | — | -$0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 |
| shares | — | 680.6M | 679.6M | 675.6M | 650.9M | 590.5M | 401.2M |
| shares | — | 680.6M | 681.9M | 678.4M | 679.4M | 599.6M | 401.2M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Medical Instruments & Supplies median 37.65×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Laboratory Solutions Segment | $4,399,700,000 | $4,610,100,000 | $4,738,300,000 | $5,002,400,000 | — | — | — | — |
| Bioscience Production Segment | $2,152,500,000 | $2,173,500,000 | $2,228,900,000 | $2,510,000,000 | — | — | — | — |
| AMEA Segment | — | — | — | — | $471,400,000 | $375,400,000 | $353,500,000 | $308,100,000 |
| Americas Segment | — | — | — | — | $4,237,400,000 | $3,731,500,000 | $3,584,800,000 | $3,460,900,000 |
| Europe Segment | — | — | — | — | $2,677,300,000 | $2,286,700,000 | $2,102,000,000 | $2,095,300,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Proprietary Materials and Consumables | $3,448,900,000 | $3,615,100,000 | $3,720,200,000 | $4,024,700,000 | $2,548,200,000 | $2,043,600,000 | $1,765,400,000 | $1,688,300,000 |
| Third Party Materials and Consumables | $3,103,300,000 | $3,168,500,000 | $3,247,000,000 | $3,487,700,000 | $2,906,300,000 | $2,671,800,000 | $2,583,600,000 | $2,570,900,000 |
| Equipment and Instrumentation | — | — | — | — | $1,009,000,000 | $860,700,000 | $912,400,000 | $909,100,000 |
| Services and Specialty Procurement | — | — | — | — | $922,600,000 | $817,500,000 | $778,900,000 | $696,000,000 |
Key facts
CIK
1722482
CUSIP
05352A100
13F (30d)
30 filings
12 filers
Visit website
Investor relations